Skip to main content

Want a detailed portfolio tracker?

Abeona Therapeutics (ABEO) P/E (2011 - 2026)

Abeona Therapeutics (ABEO) P/E from Jun 30, 2011 to Jul 21, 2026. The TTM Abeona Therapeutics (ABEO) P/E is 4.83. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Abeona Therapeutics (ABEO)

YearP/EChange
20264.83+28.89%
20253.74-225.64%
2024-2.98+28.72%
2023-2.31+892.91%
2022-0.23-51.71%
2021-0.48-69.87%
2020-1.60-30.94%
2019-2.32-71.85%
2018-8.24-85.30%
2017-56.08+226.80%
2016-17.16+44.35%
2015-11.89-2.61%
2014-12.21-19.38%
2013-15.14+66.71%
2012-9.08-99.18%
2011-1.11KN/A

Comparison Abeona Therapeutics (ABEO) P/E with competitors

Abeona Therapeutics (ABEO) P/E is 4.83.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-99.96%
NBYStablecoin Development Corp0.00-99.91%
ENLVEnlivex Ltd0.07-98.45%
FGENFibroGen Inc0.24-95.03%
CHRSCoherus Biosciences Inc0.85-82.42%
FBIOFortress Biotech Inc0.95-80.33%
ORMPOramed Pharmaceuticals Inc1.50-68.85%
AGENAgenus Inc3.01-37.63%
INVAInnoviva Inc3.15-34.64%
VXRTVaxart Inc3.55-26.44%
CRMDCorMedix Inc3.63-24.81%
CVACCureVac N.V.4.45-7.87%
GLPGGalapagos NV4.86+0.69%
SRPTSarepta Therapeutics Inc4.88+1.17%
ABUSArbutus Biopharma Corp5.60+15.96%
ZVRAZevra Therapeutics Inc5.89+22.00%
SPROSpero Therapeutics Inc6.23+29.07%
CGENCompugen Ltd6.31+30.84%
RIGLRigel Pharmaceuticals6.87+42.41%
SLXNSilexion Therapeutics Corp7.30+51.19%
OMEROmeros Corporation9.26+91.87%
AUPHAurinia Pharmaceuticals Inc9.58+98.63%
PLXProtalix BioTherapeutics Inc10.89+125.69%
ACADAcadia Pharmaceuticals Inc11.73+143.05%
TBPHTheravance Biopharma Inc12.26+154.10%
ADMAAdma Biologics Inc12.42+157.34%
HRMYHarmony Biosciences Holdings Inc13.82+186.39%
SABSSAB Biotherapeutics Inc14.14+192.94%
NAGENiagen Bioscience Inc14.82+207.07%
INCYIncyte Corp15.82+227.89%
REGNRegeneron Pharmaceuticals Inc15.86+228.59%
PBYIPuma Biotechnology Inc17.32+258.83%
CPRXCatalyst Pharmaceuticals Inc17.44+261.39%
EXELExelixis Inc17.54+263.43%
TGTXTG Therapeutics Inc18.97+293.03%
MDXGMimedx Group Inc20.55+325.90%
XOMAXOMA Royalty Corp22.87+374.04%
ARGXArgen X SE24.30+403.53%
CTMXCytomX Therapeutics Inc24.82+414.37%
XOMAOXOMA Royalty Corp25.34+425.23%
HALOHalozyme Therapeutics Inc25.62+431.01%
XOMAPXOMA Royalty Corp25.67+431.97%
VRTXVertex Pharmaceuticals Inc27.99+480.14%
RPRXRoyalty Pharma plc - Class A28.69+494.50%
SLNOSoleno Therapeutics Inc29.02+501.29%
ASNDAscendis Pharma A/S30.09+523.47%
LGNDLigand Pharmaceuticals Inc - Class B37.91+685.66%
APLSApellis Pharmaceuticals Inc39.02+708.65%
BMRNBiomarin Pharmaceutical Inc42.21+774.77%
KRYSKrystal Biotech Inc45.34+839.66%
ONCBeiGene Ltd69.54+1341.10%
PHARPharming Group N.V.75.03+1454.77%
TECHBio-Techne Corp101.96+2012.91%
VCELVericel Corp109.92+2177.93%
ALNYAlnylam Pharmaceuticals Inc117.96+2344.62%
GMABGenmab140.29+2807.28%
TLXTelix Pharmaceuticals Ltd162.15+3260.33%
CORTCorcept Therapeutics Inc212.86+4311.10%